Reviv3 Procare Co. Files 10-Q for Period Ending November 30, 2023

TL;DR

<b>Reviv3 Procare Co. filed its quarterly report (10-Q) for the period ending November 30, 2023, detailing its financial status and business operations.</b>

AI Summary

Reviv3 Procare Co (AXIL) filed a Quarterly Report (10-Q) with the SEC on January 4, 2024. The filing is a 10-Q for Reviv3 Procare Co. for the period ending November 30, 2023. The company's fiscal year ends on May 31. The business and mailing address is 901 S. Fremont Ave., Unit 158, Alhambra, CA 91803. The business phone number is 888-638-8883. The Standard Industrial Classification code is 2844 (Perfumes, Cosmetics & Other Toilet Preparations).

Why It Matters

For investors and stakeholders tracking Reviv3 Procare Co, this filing contains several important signals. This 10-Q filing provides investors with an update on Reviv3 Procare Co.'s financial performance and operational status for the most recent fiscal quarter. Understanding the details within this report is crucial for assessing the company's current financial health, strategic direction, and potential risks or opportunities.

Risk Assessment

Risk Level: low — Reviv3 Procare Co shows low risk based on this filing. The filing is a standard 10-Q, which typically contains routine financial and operational information without immediate, significant market-moving news.

Analyst Insight

Review the detailed financial statements and management discussion within the 10-Q to understand Reviv3 Procare Co.'s performance trends and outlook.

Key Numbers

• 2023-11-30 — Period End Date (Quarterly report period)
• 2024-01-04 — Filing Date (Date the report was filed)
• 2844 — SIC Code (Standard Industrial Classification for the company)

Key Players & Entities

• Reviv3 Procare Co. (company) — Filer name
• 2023-11-30 (date) — Period of report
• 2024-01-04 (date) — Filed as of date
• 0001520138-24-000008 (other) — Accession Number
• 2844 (other) — Standard Industrial Classification
• 901 S. FREMONT AVE. UNIT 158 ALHAMBRA, CA 91803 (address) — Business Address
• 888-638-8883 (phone) — Business Phone

FAQ

Industry Context

Reviv3 Procare Co. operates within the Perfumes, Cosmetics & Other Toilet Preparations industry (SIC 2844).

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial disclosures.

What Investors Should Do

1. Analyze the financial statements (balance sheet, income statement, cash flow) for the period ending November 30, 2023.
2. Review the Management's Discussion and Analysis of Financial Condition and Results of Operations for insights into performance drivers.
3. Check for any new risk factors or updates to existing ones disclosed in the filing.

Key Dates

• 2023-11-30: Quarter End — End of the reporting period for the 10-Q filing.
• 2024-01-04: Filing Date — Date the 10-Q was officially submitted to the SEC.

Year-Over-Year Comparison

This is the initial filing analyzed, so no comparison to a previous filing is available.

Key Financial Figures

• $0.0001 — shares of the registrants common stock, $0.0001 par value, outstanding. REVIV3 PROCAR

Filing Documents

• rviv-20231130_10q.htm (10-Q) — 1215KB
• rviv-20231130_10qex31z1.htm (EX-31.1) — 12KB
• rviv-20231130_10qex31z2.htm (EX-31.2) — 12KB
• rviv-20231130_10qex32z1.htm (EX-32.1) — 6KB
• rviv-20231130_10qex32z2.htm (EX-32.2) — 6KB
• 0001520138-24-000008.txt (&nbsp;) — 6607KB
• rviv-20231130.xsd (EX-101.SCH) — 55KB
• rviv-20231130_cal.xml (EX-101.CAL) — 62KB
• rviv-20231130_def.xml (EX-101.DEF) — 139KB
• rviv-20231130_lab.xml (EX-101.LAB) — 335KB
• rviv-20231130_pre.xml (EX-101.PRE) — 285KB
• rviv-20231130_10q_htm.xml (XML) — 1288KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1. Financial 1 Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations 2 Item 3. Quantitative and Qualitative Disclosures About Market Risk 7 Item 4. Controls and Procedures 7 PART II - OTHER INFORMATION Item 1. Legal Proceedings 8 Item 1A. Risk Factors 8 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 8 Item 3. Defaults Upon Senior Securities 8 Item 4. Mine Safety Disclosures 8 Item 5. Other Information 8 Item 6. Exhibits 9

Signatures

Signatures 10 -i- Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q, in particular Part I, Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding our assumptions about financial performance; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations; and the economy in general or the future of the beauty and hair care industry and the hearing protection and ear bud business, all of which are subject to various risks and uncertainties. There are a number of factors that could cause our actual results to differ from those indicated in the forward-looking statements, many of which are outside of our control. They include: the impact of unstable market and general economic conditions on our business, financial condition and stock price, including inflationary cost pressures, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the Ukraine-Russia conflict, the effects of the Israel-Hamas conflict, and other downturns in the business cycle or the economy; our financial performance and liquidity, including our ability to successfully generate sufficient revenue to support our operations; our ability to repay our outstanding loans, if

View Full Filing

View this 10-Q filing on SEC EDGAR